Navigation Links
Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented

REGENSBURG, Germany, May 10th, 2007 - Antisense Pharma today announced, that the abstract entitled “Preliminary Results of a Phase I/II-Study in Pancreatic Carcinoma, Malignant Melanoma, and Colorectal Carcinoma with the TGF-beta2 Inhibitor AP 12009” has been selected for poster presentation at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held in Chicago, Illinois, U.S.A, from June 1st - 5th.

In the Phase I/II-trial the antisense drug AP 12009 is administered intravenously in patients with either pancreatic carcinoma (stage IVA/IVB), metastatic melanoma (stage III/IV), or advanced colorectal carcinoma (stage III/IV) as a 7-day continuous infusion every other week. “The first milestone of the study has been achieved, as the maximum tolerated dose was determined with this treatment schedule”, explains Hubert Heinrichs, M.D., Ph.D., Chief Medical Officer at Antisense Pharma. Patient recruitment is still ongoing in study sites in Germany as further dose escalations with a modified dosing schedule are now performed. The design of the study, first efficacy and safety data will be presented at the poster presentation (Poster Board No. AA5, Abstract ID 4607) on June 4th 2007 from 8:00 a.m. to 12:00 p.m. in the session “Gastrointestinal (Noncolorectal) Cancer”. Prof. Thomas Seufferlein, Vice Head of the Department of Internal Medicine at the University of Ulm and Principal Investigator of the Phase I/II-Study will be available for questions from 11:00 a.m. to 12:00 p.m. at the poster in Hall A2 on Level 3 of McCormick Place South Building.

About Antisense Pharma

Antisense Pharma is a biopharmaceutical company located in Regensburg, Germany. The company focuses on targeted therapies for malignant tumors and is dedicated to discovering and developing drugs based on antisense technology for worldwide commercialization.


'"/>




Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Phase data Systemic Application the TGF beta2 inhibitor Presented
(Date:3/3/2015)... 2015  Columbia Laboratories, Inc. (Nasdaq: CBRX ... a specialty pharmaceutical company focused on pharmaceuticals for women,s ... 27th Annual ROTH Conference, which will take place from ... Dana Point, California . Management,s presentation will ... Pacific Time (12:00 p.m. Eastern Time) in the Promenade ...
(Date:3/3/2015)... Spain , March 3, 2015  AT&T 1 ... PHIA) today announced that  AT&T  is the connectivity provider ... GoSafe was designed to help provide peace of mind ... them the freedom to live active lives with the ... they need it. The AT&T network 2 helps ...
(Date:3/3/2015)... -- Today, the Partnership for Prescription Assistance (PPA), ... companies, unveiled a redesigned website with ... caregivers with faster, easier access to information on ... programs. Since its launch in ... educate and empower patients and caregivers to access ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2
... N.Y., Sept. 29 International Business ... (MHIN) will jointly present the 7th Annual MidAmerica ... Wisconsin Technology Council. The conference brings together ... corporate business development executives, angel investors, investment bankers, ...
... Aesthetics, a science-based medical device company dedicated to the development ... has announced the appointment of Gordie Nye as ... founder of Zeltiq Aesthetics, who served as President since September ... the Board of Directors since 2006. Mr. Levinson will ...
Cached Medicine Technology:Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 2Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 3Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 4Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3
(Date:3/3/2015)... Findings could lead to better therapies against many ... and characterized a molecule that interferes with the internal ... novel mechanism was found to be effective against glioma ... brain cancer – and could be applicable to other ... published in the April 2015 issue of Molecular Pharmacology, ...
(Date:3/3/2015)... The Rheumatology Nurses Society (RNS) is ... and safe practice for patients with rheumatic diseases. , ... infusions are administered in an infusion center, provider’s office, ... nurse (RN), as defined in their State Nurse Practice ... receiving these medications during a first infusion, as well ...
(Date:3/3/2015)... Dallas, TX (PRWEB) March 04, 2015 ... comprehensive information on the therapeutic development for Alopecia. Alopecia ... alopecia are the two main types of alopecia. Causes ... autoimmune disorder. Symptoms of alopecia may include male pattern ... and broken hair. Alopecia can be classified as focal ...
(Date:3/3/2015)... Daylight Savings Time may lead to your ... tips for parents. , Parents and their children may feel ... when they set their clocks forward one hour for Daylight ... -- one hour earlier -- you will have already lost ... thinking about “sleep hygiene” for their kids and teens this ...
(Date:3/3/2015)... Today is International Ear Care Day, and the ... applaud and promote the launch of Make Listening Safe, ... for stemming the threat of noise-induced hearing loss. , ... practice safe listening when they recreate, be that listening ... or engaging in other forms of entertainment. , ...
Breaking Medicine News(10 mins):Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:ASHA Applauds Launch of New WHO Campaign 2
... Families, Caregivers and Individuals at risk are encouraged to learn ... and live with it during Heart Failure Awareness Week February ... (HFSA) Provides 11 Fact-Filled Education Modules Available at ... National Heart Failure Awareness Week is set for February ...
... Topical Agent With a Novel Mechanism of Action ... Patient Share in the U.S. Than in Europe, ... Mass., Feb. 9 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that high and ...
... GROVE, Ill., Feb. 9 Lifeway Foods, Inc., (Nasdaq: ... dairy beverage called Kefir, today announced the acquisition of ... market with a #2 overall market share. The ... for probiotic dairy products. Fresh Made had 2008 ...
... research that delivers,timely studies with operational insights on vital ... available in the Best,Practice Database, an online research repository ... To review sample key findings ... a landing page with links to each of the ...
... Layoffs result from recent challenges, effort to reduce costsST. ... (NYSE: KVa/KVb) announced today it is in the process ... The action is part of an overall cost-cutting program ... The company has encountered a number of substantial challenges ...
... things associated with the holiday from fruit and wine to ... Feb. 9 The sweet delights of Valentine,s Day are ... can be good for your heart, says a University ... enjoying food and wine, but there are components in tart ...
Cached Medicine News:Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 2Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 3Health News:High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources' Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis 2Health News:Lifeway Foods Acquires Philadelphia Based Fresh Made Dairy, the Nation's Second Largest Kefir Manufacturer 2Health News:Lifeway Foods Acquires Philadelphia Based Fresh Made Dairy, the Nation's Second Largest Kefir Manufacturer 3Health News:Lifeway Foods Acquires Philadelphia Based Fresh Made Dairy, the Nation's Second Largest Kefir Manufacturer 4Health News:Best Practice Database adds Research Highlighting the Value of Internal Consulting and Early-Stage Commercialization Groups in the Pharmaceutical Industry 2Health News:KV Pharmaceutical Company Reduces Workforce 2Health News:KV Pharmaceutical Company Reduces Workforce 3Health News:KV Pharmaceutical Company Reduces Workforce 4Health News:KV Pharmaceutical Company Reduces Workforce 5Health News:Valentine's Day Indulgences Can Be Heart Healthy 2Health News:Valentine's Day Indulgences Can Be Heart Healthy 3
The AVOXimeter 1000E measures:, Oxygen saturation (for diagnosing shunts) , Oxygen content (for Fick Principle calculations), Total hemoglobin concentration , ,Ideal for adult and pediatri...
Inquire...
... In ocular fundus perimetry, the visual field ... displayed on the screen. By overlapping the ... you can grasp the correspondence between the ... Digital imaging system enabling practices to totally ...
SkinStation, powered by LHE, is Radiancys flagship product. A powerhouse by design, it incorporates todays most sought after applications all on one user-friendly system ....
Medicine Products: